Erudio Healtherudio.com
Drug
Anbenitamab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying anbenitamab: Neo-Healer. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| Neo-Healer NCT06747338 · Shanghai JMT-Bio Inc. | early or locally advanced HER2-positive breast cancer | Phase 3 | 104 | 21 | Focused | Nov 20, 2026 | Preview |